Neonatal Parameters in the 24 Thrombocytopenic Neonates
| Patient No. . | Platelet Count × 109/L . | Nadir (day) . | Normalization of Platelet Count (day) . | Treatment . | Associated Pathology . | |
|---|---|---|---|---|---|---|
| At Birth . | At Nadir . | |||||
| 1 | 62 | 40 | (10) | ND | ND | None |
| 2a | 59 | 15 | (14) | ND | ND | None |
| 2b | ND | 16 | (3) | ND | ND | None |
| 2c | 112 | 43 | (4) | ND | IVIgG | None |
| 4 | 193 | 80 | (5) | (8) | IVIgG | Materno-foetal infection |
| 6a | 160 | 16 | (4) | ND | IVIgG | None |
| 6b | 25 | 25 | (0) | (16) | IVIgG | None |
| 10 | 49 | 49 | (0) | (9) | IVIgG | None |
| 15 | 123 | 90 | (4) | (12) | ND | None |
| 16 | 17 | 14 | (5) | (24) | IVIgG | None |
| 17 | 219 | 105 | (5) | (8) | ND | None |
| 19a | 360 | 100 | (1) | ND | None | IUGR |
| 24 | 140 | ND | ND | ND | None | Viral infection |
| 295-150 | 75 | 13 | (15) | (>68) | OS | None |
| 33 | >150 | 20 | (7) | (10) | IVIgG | None |
| 36a | 70 | 20 | (1) | ND | IVIgG | None |
| 36b | 24 | 24 | (0) | ND | IVIgG | None |
| 37 | ND | 37 | (3) | ND | None | None |
| 39 | ND | 45 | (5) | ND | ND | None |
| 41a | 128 | 46 | (3) | ND | IVIgG | None |
| 41b | 105 | 45 | (2) | ND | None | None |
| 42a | 250 | 93 | (5) | ND | ND | None |
| 45 | 103 | 103 | (0) | ND | None | None |
| 46 | 90 | 90 | (0) | ND | None | None |
| Patient No. . | Platelet Count × 109/L . | Nadir (day) . | Normalization of Platelet Count (day) . | Treatment . | Associated Pathology . | |
|---|---|---|---|---|---|---|
| At Birth . | At Nadir . | |||||
| 1 | 62 | 40 | (10) | ND | ND | None |
| 2a | 59 | 15 | (14) | ND | ND | None |
| 2b | ND | 16 | (3) | ND | ND | None |
| 2c | 112 | 43 | (4) | ND | IVIgG | None |
| 4 | 193 | 80 | (5) | (8) | IVIgG | Materno-foetal infection |
| 6a | 160 | 16 | (4) | ND | IVIgG | None |
| 6b | 25 | 25 | (0) | (16) | IVIgG | None |
| 10 | 49 | 49 | (0) | (9) | IVIgG | None |
| 15 | 123 | 90 | (4) | (12) | ND | None |
| 16 | 17 | 14 | (5) | (24) | IVIgG | None |
| 17 | 219 | 105 | (5) | (8) | ND | None |
| 19a | 360 | 100 | (1) | ND | None | IUGR |
| 24 | 140 | ND | ND | ND | None | Viral infection |
| 295-150 | 75 | 13 | (15) | (>68) | OS | None |
| 33 | >150 | 20 | (7) | (10) | IVIgG | None |
| 36a | 70 | 20 | (1) | ND | IVIgG | None |
| 36b | 24 | 24 | (0) | ND | IVIgG | None |
| 37 | ND | 37 | (3) | ND | None | None |
| 39 | ND | 45 | (5) | ND | ND | None |
| 41a | 128 | 46 | (3) | ND | IVIgG | None |
| 41b | 105 | 45 | (2) | ND | None | None |
| 42a | 250 | 93 | (5) | ND | ND | None |
| 45 | 103 | 103 | (0) | ND | None | None |
| 46 | 90 | 90 | (0) | ND | None | None |
Abbreviations: a, first neonate; b, second neonate; c, third neonate; ND, not determined; IVIgG, intravenous Igs; OS, oral steroids; IUGR, intrauterine growth retardation.
Bleeding symptoms (petechiae and scalp hematoma).